NL-OMON50413
Recruiting
Not Applicable
Predictive biomarkers and the role of the microbiome determining response to antiinflammatory treatment in Inflammatory Bowel Disease (Crohn's disease and ulcerative colitis) - Predictive biomarkers and the role of microbiome on treatment for IBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Crohn's disease
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 2240
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Crohn's disease
- •ulcerative colitis
- •Inflammatory Bowel disease
Exclusion Criteria
- •ongoing malignancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
The analysis of the microbiota as biomarkers of response to anticancer drugs in metastatic solid cancersJPRN-UMIN000030778Department of Internal Medicine, Division of Medical Oncology, Showa University School of Medicine.60
Completed
Not Applicable
Analysis of biomarker and microbiome profile and assessment of clinical effectiveness for diagnosis of Chronic PeriodontitisDiseases of the digestive systemKCT0006071Seoul National University Dental Hospital100
Recruiting
Not Applicable
Identification of Biomarkers and Microbiota Specific for Plaque Erosion and Layered Plaque in Patients with Acute Coronary Syndromes: A prospective OCT studyAcute coronary syndromeJPRN-UMIN000047254Massachusetts General Hospital100
Completed
Not Applicable
The intestinal microbiome as a predictive biomarker for efficacy and side effects of CAR-T cell therapy in blood cancersC91.0C83.3Acute lymphoblastic leukaemia [ALL]Diffuse large B-cell lymphomaDRKS00020506Deutsches Krebsforschungszentrum (DKFZ)66
Completed
Not Applicable
Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and ToxicityNCT04954885Ohio State University Comprehensive Cancer Center2